CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 4 Open-market sale CFO sold 104 shares at $0.04 ($4)
- 4 Open-market sale Director sold 10 shares at $0.62 ($6)
- 5 Insider Annual Insider Trading Report
- 4 Returned to the company Chief Executive Officer returned 50,000 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 141,000 shares at $0.35 ($49,703)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel and Secretary acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 450,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 750,000 shares (grant or award)
- 4 Returned to the company General Counsel and Secretary returned 120,000 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 120,000 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 300,000 shares (to the company)
- 4 Open-market buy General Counsel and Secretary bought 25,000 shares at $0.39 ($9,725)
Page 1 of 15 · 281 filings